Moore's law of components, "a component being a transistor, resistor, diode or capacitor", at minimum cost. Transistors per integrated circuit – The most popular formulation is of the doubling of the number of transistors on integrated circuits every two years. At the end of the 1970s, Moore's law became known as the limit for the number of transistors on the most complex chips. The graph at the top shows this trend holds true today. Density at minimum cost per transistor – This is the formulation given in Moore's 1965 paper. It is not just about the density of transistors that can be
SmithKline Corp. v. Eli Lilly & Co. Kefzol and SK's Ancef—identical to one another—were cheaper, partial substitutes for patented Keflin, which had a higher sales price and generated more profit but was cheaper to manufacture than the other two. Keflin accounted for most of Lilly's cephalosporin sales. Kefzol/Ancef, however, was cutting into Keflin sales as hospitals partially substituted cheaper, and in some ways better, Kefzol/Ancef for Keflin. Nalebuff explains: The bundling program "was effective at keeping SmithKline out of the market while also preserving Keflin's monopoly," because: SmithKline Corp. v. Eli Lilly & Co. SmithKline Corp. v. Eli Lilly and Co., 575 F.2d 1056 (3d Cir. 1978),